SlideShare a Scribd company logo
Magdy El-Masry
Prof. of Cardiology
Tanta University
CHANGES IN BLOOD
PRESSURE AFTER
HEMODIALYSIS
Hemodialysis
Removal of Fluid and Solutes with the Goal to Achieve
“Dry Weight”
What the cardiologist should know ?
Hemodialysis Basics
Diffusion
Convection
Goals of Dialysis
–Solute clearance
• Diffusive transport (based on countercurrent
flow of blood and dialysate)
• Convective transport (solvent drag with
ultrafiltration)
–Fluid removal
11
Figure 3-2
Body Fluid Compartments
Appropriate Removal Rate
setting the fluid removal rate to not exceed
the plasma refill rate (PRR) will minimize
risk of hypovolemia, hypotension
“Never too fast, never too much”
Vascular
Space
Plasma
Refill
Rate
Intravascular
Hemodialysis
UF rate
Extravascular
UFR ≤ PRR
(UFR)UltrafiltrationRemoval byFluid
illicits compensatory mechanisms, termed
plasma or intravascular refill, aimed at
minimizing this reduction
Dialysate Buffer
• Acetate: in the early 1960s became the
standard dialysate buffer used to correct
uremic acidosis
In the mid 1980s some reported the linking
between acetate and cardiovascular
instability and hypotension during HD
• Bicarbonate: emerged the buffer of choice
Dialysis Solution Sodium Level
Plus Minus
Low
dialysate
sodium
Less weight-gain,
thirst
&hypertension
More hypotension,
cramps
High
dialysate
sodium
Less hypotension,
cramps
More weight gain,
thirst
& hypertension
EXCESS FLUID WEIGHT
Body weight at which composition of
body fluid compartments is normal.
At higher weights there is expansion
of compartments
At lower weights there is depletion
of compartments.
Both these states have adverse
clincal consequences.
CONCEPT of DRY WEIGHT
DRY WEIGHT
(euvolemia)
In short, among all these elements, the 2 essential
clues are the BP and the weight
Intradialytic Hypotension
Acute complications of dialysis
HHCCBNF
• Hypotension — 25 to 55 %
• Cramps — 5 to 20 %
• Nausea and vomiting — 5 to 15 %
• Headache — 5%
• Chest pain — 2 to 5 %
• Back pain — 2 to 5 %
• Itching — 5 %
• Fever and chills — Less than 1 %
Intradialytic
Hypotension
K/DOQI
• ↓SBP≥20mmHg or ↓MAP 10mmHg
with symptoms:
abdominal discomfort,
yawning, sighing, N/V, cramps,
restlessness, anxiety, fainting
Cardiac output
Arterial Blood Pressure
Diastolic filling
Atrial kick
Systemic vascular resistance
Stroke volume
preload afterload contractility
Heart rate / rhythm
Ultrafiltration
Osmolality
Fall
Warm
Dialysate
Bio-incom-
patibility
Endotoxin
Acetate
Infusion
Volume
Vasopressors
Vasodilatator
Cell
Dysfunction
Complement
Activation,
Cytokine release
Hypoxemia
Heart Disease
Vascular
Disease
Autonomic
Dysfunction
Hormonal
Dysfunction
Medications
Sepsis
Infection
Vasovagal
stim.
HYPOTENSION
CARDIAC
OUTPUT
PERIPHERAL
RESISTANCE
PATHOGENESIS MEDIATORS PATHOPHYSIOLOGY PATIENT
Acute management of low blood pressure
associated with hemodialysis
Ultrafiltration should either be stopped or the
rate decreased.
The patient should be placed in the
Trendelenburg position.
The blood flow rate should be reduced.
Intravascular volume may be replaced with
mannitol or saline. Currently the use of an
intravenous bolus of saline is the first-line
therapy for hypotension.
PREVENTION
• Accurate setting of the "dry weight"
• Steady, constant ultrafiltration
• Increased dialysate sodium concentration and
sodium modeling
• Bicarbonate dialysate buffer
• Decrease dialysate temperature from 37C to
34-35C
Prevention – Con’t
Improvement in cardiovascular Performance in
cardiac patients.
Midodrine (the selective alpha-1 adrenergic
agonist) in patients with autonomic neuropathy and
perhaps others with severe hemodialysis
hypotension not responsive to the above measures.
Avoidance of food.
Avoid large interdialytic weight gain
No antihypertensive before dialysis
Intradialytic Hypertension
The growing problem of
intradialytic hypertension
(5 – 15 % of HD patients )
Intradialytic Hypertension
Clinical Definitions
• ↑MAP of ≥ 15 mmHg during or
immediately post dialysis
• Hypertension during 2nd or 3rd hr
of HD after significant UF removed
• ↑BP that is resistant to UF
The Etiopathogenesis of Intradialytic Hypertension
Hypervolemia
Sodium balance positive and extracellular volume expand
Increased systemic vascular resistance
Increased sympathetic activity
Renin-angiotensin system hyperactivity
Endothelial cell dysfunction
Elevated concentration of endothelin 1
Calcification of the arterial tree
Increased hematocrit
Erythropoietin Therapy
Increased vascular stiffness
Nitric oxide deficiency
Hypertension in dialysis
(Another World
• There are limited studies on controlling blood
pressure in patients on dialysis.
• No consistent guidelines available due to the
fact that no one knows what blood pressure to
target.
– Pre, Post, intradialytic, non-dialysis day.
Blood pressure measurement
in dialysis patients
 Majority of Uremic patients lack diurnal variation in BP
 Immediate pre‐dialysis and post‐dialysis are misleading and not
reflective of true interdialytic BP
However, a post dialytic BP is more reflective of interdialytic BP
*Continuous monitoring is warranted in poor control patients
(those with large interdialytic weight gain)
*“Systolic load “ ‐‐ > amount of time SBP exceeds 140 mmHg per
day as correlates to incidence of LVH
K/DOQI
Blood Pressure Goals in Hypertensive ESRD Patients
• Target BP ≤ 140/90 mmHg (predialysis)
• ≤ 130/80 mmHg (postdialysis)
Treatment of hypertension in
patients on hemodialysis
Treatment of hypertension is often a multiple-step,
multidisciplinary process to reach KDOQI guidelines
of predialysis BP values of <140/90 mm Hg.
The key to successful treatment is patience; it often
takes 4-6 weeks to achieve results.
(This represents the lag phenomenon )
Chronic
volume
expansion
Vascular Na/K
ATPase
NO Synthetase
ADMA
DLIS etc
NO
iCa++
Vaso-
constriction
Sustained UF & Na restriction
ECV
DLIS etc
ADMA
LAG
BP
Lag period between normalisation of
ECF and optimal control of BP
DLIS:digoxin-like immunoreactive substance ADMA:asymmetric-dimethyl arginine
Treatment of Intradialytic Hypertension
The step-by-step approach
Choice of antihypertensive drugs
All classes of antihypertensive drugs can be used
in dialysis patients, with the sole exception of
diuretics, which are not commonly used because
of their lack of efficacy.
Therefore, with the exceptions of diuretics, the
criteria for drug selection are quite similar to
those used in non-dialysis patients.
Dialysis Clearance of Drugs
In general, removal of drugs on HD has NOT
been tested and is based on theoretical
considerations of molecular size and chemical
makeup of the drug
Drugs with low MW, limited volume of
distribution (Vd) , and that are water-soluble are
most likely to be removed by HD and will require
extra dosing
Postdialysis dosing or extra doses after HD may
be necessary for certain antihypertensive agents:
•Angiotensin converting enzyme inhibitors (ACE-I): all are
dialyzable except fosinopril
•Angiotensin receptor blockers (ARB): none are dialyzed
•B-blockers: atenolol and metoprolol are dialyzable but
labetolol and carvedilol are not
•Calcium channel blocker: amlodipine is not dialyzable
Conclusions
“We can do better”
The fluctuations in BP
with every dialysis is
complex
Intradialytic Blood Pressure Fluctuations
• Current State
Clinically significant alteration in blood pressures
is one of the biggest challenges encountered in
the dialysis unit
• Ideal State
Clinicians understand the physiological changes
in blood pressures during hemodialysis and
prevent and manage these changes effectively to
ensure patient’s safety
Thank you for your attention
Gracias por su atención
Danke für Ihre Aufmerksamkeit
Go raibh maith agat
Grazie per l´Attenzione
AAp sAAb kA shukriyA…
Merci pour votre attention

More Related Content

What's hot

Complication during hemodialysis
Complication during hemodialysisComplication during hemodialysis
Complication during hemodialysis
mohammad saad forghani
 
Acute Heart Failure - Pharmacotherapy
Acute Heart Failure - PharmacotherapyAcute Heart Failure - Pharmacotherapy
Acute Heart Failure - Pharmacotherapy
Areej Abu Hanieh
 
Recent Advances in CCF
Recent Advances in CCFRecent Advances in CCF
Recent Advances in CCF
Dr Ketan Asawalle
 
complications of HD case presentation
complications of HD case presentationcomplications of HD case presentation
complications of HD case presentation
Dr. Abrar Ali Katpar
 
Spotlight on complication during hemodialysis
Spotlight on complication during hemodialysisSpotlight on complication during hemodialysis
Spotlight on complication during hemodialysis
mohamed hassan abbass
 
Specific organ support in icu
Specific organ support in icuSpecific organ support in icu
Specific organ support in icu
Dr fakhir Raza
 
Congestive Heart Failure Latest Guidelines and Recent Advances in Drug treatm...
Congestive Heart Failure Latest Guidelines and Recent Advances in Drug treatm...Congestive Heart Failure Latest Guidelines and Recent Advances in Drug treatm...
Congestive Heart Failure Latest Guidelines and Recent Advances in Drug treatm...
Rahul Bhati
 
Renovascular hypertension in children
Renovascular hypertension in childrenRenovascular hypertension in children
Renovascular hypertension in children
Faheem Andrabi
 
Causes of hypotension during dialysis by aniqa atta
Causes of hypotension during dialysis by aniqa attaCauses of hypotension during dialysis by aniqa atta
Causes of hypotension during dialysis by aniqa atta
aniqaatta1
 
Phamacological Management of Essential Hypertension - Revision Guide
Phamacological Management of Essential Hypertension - Revision GuidePhamacological Management of Essential Hypertension - Revision Guide
Phamacological Management of Essential Hypertension - Revision Guidemeducationdotnet
 
Acutely Sick Cardiac Patient
Acutely Sick Cardiac PatientAcutely Sick Cardiac Patient
Acutely Sick Cardiac Patient
MEEQAT HOSPITAL
 
note of acute heart failure
note of acute heart failurenote of acute heart failure
note of acute heart failure
元傑 張
 
Recent advances in management of heart failure
Recent advances in management of heart failureRecent advances in management of heart failure
Recent advances in management of heart failure
rahul arora
 
Complications of hemodialysis
Complications of hemodialysisComplications of hemodialysis
Complications of hemodialysis
أحمد عبد الوهاب الجندي
 
Hypertensive Emergencies
Hypertensive EmergenciesHypertensive Emergencies
Hypertensive Emergencies
Rebecca Omozuapo
 
Precath preparation
Precath preparationPrecath preparation
Precath preparationFuad Farooq
 
Blood pressure & Its Prosthodontic Implication
Blood pressure & Its Prosthodontic Implication Blood pressure & Its Prosthodontic Implication
Blood pressure & Its Prosthodontic Implication
Self employed
 
Advances in Medical Management of Heart Failure
Advances in Medical Management of Heart FailureAdvances in Medical Management of Heart Failure
Advances in Medical Management of Heart Failure
Praveen Nagula
 

What's hot (20)

Complication during hemodialysis
Complication during hemodialysisComplication during hemodialysis
Complication during hemodialysis
 
Acute Heart Failure - Pharmacotherapy
Acute Heart Failure - PharmacotherapyAcute Heart Failure - Pharmacotherapy
Acute Heart Failure - Pharmacotherapy
 
Recent Advances in CCF
Recent Advances in CCFRecent Advances in CCF
Recent Advances in CCF
 
complications of HD case presentation
complications of HD case presentationcomplications of HD case presentation
complications of HD case presentation
 
Spotlight on complication during hemodialysis
Spotlight on complication during hemodialysisSpotlight on complication during hemodialysis
Spotlight on complication during hemodialysis
 
Intradialytic hypotension
Intradialytic hypotensionIntradialytic hypotension
Intradialytic hypotension
 
Specific organ support in icu
Specific organ support in icuSpecific organ support in icu
Specific organ support in icu
 
Congestive Heart Failure Latest Guidelines and Recent Advances in Drug treatm...
Congestive Heart Failure Latest Guidelines and Recent Advances in Drug treatm...Congestive Heart Failure Latest Guidelines and Recent Advances in Drug treatm...
Congestive Heart Failure Latest Guidelines and Recent Advances in Drug treatm...
 
Renovascular hypertension in children
Renovascular hypertension in childrenRenovascular hypertension in children
Renovascular hypertension in children
 
Causes of hypotension during dialysis by aniqa atta
Causes of hypotension during dialysis by aniqa attaCauses of hypotension during dialysis by aniqa atta
Causes of hypotension during dialysis by aniqa atta
 
Heartfailure
HeartfailureHeartfailure
Heartfailure
 
Phamacological Management of Essential Hypertension - Revision Guide
Phamacological Management of Essential Hypertension - Revision GuidePhamacological Management of Essential Hypertension - Revision Guide
Phamacological Management of Essential Hypertension - Revision Guide
 
Acutely Sick Cardiac Patient
Acutely Sick Cardiac PatientAcutely Sick Cardiac Patient
Acutely Sick Cardiac Patient
 
note of acute heart failure
note of acute heart failurenote of acute heart failure
note of acute heart failure
 
Recent advances in management of heart failure
Recent advances in management of heart failureRecent advances in management of heart failure
Recent advances in management of heart failure
 
Complications of hemodialysis
Complications of hemodialysisComplications of hemodialysis
Complications of hemodialysis
 
Hypertensive Emergencies
Hypertensive EmergenciesHypertensive Emergencies
Hypertensive Emergencies
 
Precath preparation
Precath preparationPrecath preparation
Precath preparation
 
Blood pressure & Its Prosthodontic Implication
Blood pressure & Its Prosthodontic Implication Blood pressure & Its Prosthodontic Implication
Blood pressure & Its Prosthodontic Implication
 
Advances in Medical Management of Heart Failure
Advances in Medical Management of Heart FailureAdvances in Medical Management of Heart Failure
Advances in Medical Management of Heart Failure
 

Similar to Bloodpressurechangesduring

Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
O. E.Nyandi PhD
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
logon2kingofkings
 
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
O. E.Nyandi PhD
 
Overview of the Medical Management of High Blood Pressure in Adults
Overview of the Medical Management of High Blood Pressure in AdultsOverview of the Medical Management of High Blood Pressure in Adults
Overview of the Medical Management of High Blood Pressure in Adults
Luis Daniel Lugo
 
CONGESTIVE HEART FAILURE.pptx
CONGESTIVE HEART FAILURE.pptxCONGESTIVE HEART FAILURE.pptx
CONGESTIVE HEART FAILURE.pptx
Anjana KS
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
Maged Abulmagd
 
CVS pharmacology.pdf
CVS pharmacology.pdfCVS pharmacology.pdf
CVS pharmacology.pdf
Obsa2
 
Hf. final
Hf. finalHf. final
Hf. final
Rahul Rai
 
lecture-3 hypertantion.pdf
lecture-3 hypertantion.pdflecture-3 hypertantion.pdf
lecture-3 hypertantion.pdf
Obsa2
 
Pharmacotherapy, Management of Hypertension, JNC 8 guidelines
Pharmacotherapy, Management of Hypertension, JNC 8 guidelinesPharmacotherapy, Management of Hypertension, JNC 8 guidelines
Pharmacotherapy, Management of Hypertension, JNC 8 guidelines
ankitamishra1402
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
Subramani Parasuraman
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
Damascus University
 
Cardiomyopathy and anesthetic concern
Cardiomyopathy and anesthetic concernCardiomyopathy and anesthetic concern
Cardiomyopathy and anesthetic concern
Umang Sharma
 
Heart Failure Seminar
 Heart Failure Seminar Heart Failure Seminar
Heart Failure Seminar
Tellmehowtobreathwithnoair
 
heart failure .pptx
heart failure .pptxheart failure .pptx
heart failure .pptx
SuhailRafik1
 
Chronic Heart Failure- Pharmacotherapy
Chronic Heart Failure-  PharmacotherapyChronic Heart Failure-  Pharmacotherapy
Chronic Heart Failure- Pharmacotherapy
Areej Abu Hanieh
 
Renal failure and renal replacement therapy
Renal failure and renal replacement  therapyRenal failure and renal replacement  therapy
Renal failure and renal replacement therapy
Ivan Luyimbazi
 
Renal failure and renal replacement therapy
Renal failure and renal replacement  therapyRenal failure and renal replacement  therapy
Renal failure and renal replacement therapy
Ivan Luyimbazi
 
11241869.ppt
11241869.ppt11241869.ppt
11241869.ppt
ssuser497f37
 

Similar to Bloodpressurechangesduring (20)

Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
 
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
 
Overview of the Medical Management of High Blood Pressure in Adults
Overview of the Medical Management of High Blood Pressure in AdultsOverview of the Medical Management of High Blood Pressure in Adults
Overview of the Medical Management of High Blood Pressure in Adults
 
CONGESTIVE HEART FAILURE.pptx
CONGESTIVE HEART FAILURE.pptxCONGESTIVE HEART FAILURE.pptx
CONGESTIVE HEART FAILURE.pptx
 
HYPERTENSIVE CRISIS
HYPERTENSIVE CRISISHYPERTENSIVE CRISIS
HYPERTENSIVE CRISIS
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
 
CVS pharmacology.pdf
CVS pharmacology.pdfCVS pharmacology.pdf
CVS pharmacology.pdf
 
Hf. final
Hf. finalHf. final
Hf. final
 
lecture-3 hypertantion.pdf
lecture-3 hypertantion.pdflecture-3 hypertantion.pdf
lecture-3 hypertantion.pdf
 
Pharmacotherapy, Management of Hypertension, JNC 8 guidelines
Pharmacotherapy, Management of Hypertension, JNC 8 guidelinesPharmacotherapy, Management of Hypertension, JNC 8 guidelines
Pharmacotherapy, Management of Hypertension, JNC 8 guidelines
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
Cardiomyopathy and anesthetic concern
Cardiomyopathy and anesthetic concernCardiomyopathy and anesthetic concern
Cardiomyopathy and anesthetic concern
 
Heart Failure Seminar
 Heart Failure Seminar Heart Failure Seminar
Heart Failure Seminar
 
heart failure .pptx
heart failure .pptxheart failure .pptx
heart failure .pptx
 
Chronic Heart Failure- Pharmacotherapy
Chronic Heart Failure-  PharmacotherapyChronic Heart Failure-  Pharmacotherapy
Chronic Heart Failure- Pharmacotherapy
 
Renal failure and renal replacement therapy
Renal failure and renal replacement  therapyRenal failure and renal replacement  therapy
Renal failure and renal replacement therapy
 
Renal failure and renal replacement therapy
Renal failure and renal replacement  therapyRenal failure and renal replacement  therapy
Renal failure and renal replacement therapy
 
11241869.ppt
11241869.ppt11241869.ppt
11241869.ppt
 

More from Saleh Al-Qarni

Better understanding of blood gases
Better understanding of blood gasesBetter understanding of blood gases
Better understanding of blood gases
Saleh Al-Qarni
 
Blood gas interpretation
Blood gas interpretationBlood gas interpretation
Blood gas interpretation
Saleh Al-Qarni
 
Pharma collection 2
Pharma collection 2Pharma collection 2
Pharma collection 2
Saleh Al-Qarni
 
Pharma collection
Pharma collectionPharma collection
Pharma collection
Saleh Al-Qarni
 
All normal range
All normal range   All normal range
All normal range
Saleh Al-Qarni
 
Arthritis and bad posture
Arthritis and bad postureArthritis and bad posture
Arthritis and bad posture
Saleh Al-Qarni
 
Diureticresistence
DiureticresistenceDiureticresistence
Diureticresistence
Saleh Al-Qarni
 
Myocarditis
Myocarditis Myocarditis
Myocarditis
Saleh Al-Qarni
 
Myocarditis 140103113606-phpapp02
Myocarditis 140103113606-phpapp02Myocarditis 140103113606-phpapp02
Myocarditis 140103113606-phpapp02
Saleh Al-Qarni
 
Labs 1.08-abg-rome-flowchart
Labs 1.08-abg-rome-flowchartLabs 1.08-abg-rome-flowchart
Labs 1.08-abg-rome-flowchart
Saleh Al-Qarni
 

More from Saleh Al-Qarni (10)

Better understanding of blood gases
Better understanding of blood gasesBetter understanding of blood gases
Better understanding of blood gases
 
Blood gas interpretation
Blood gas interpretationBlood gas interpretation
Blood gas interpretation
 
Pharma collection 2
Pharma collection 2Pharma collection 2
Pharma collection 2
 
Pharma collection
Pharma collectionPharma collection
Pharma collection
 
All normal range
All normal range   All normal range
All normal range
 
Arthritis and bad posture
Arthritis and bad postureArthritis and bad posture
Arthritis and bad posture
 
Diureticresistence
DiureticresistenceDiureticresistence
Diureticresistence
 
Myocarditis
Myocarditis Myocarditis
Myocarditis
 
Myocarditis 140103113606-phpapp02
Myocarditis 140103113606-phpapp02Myocarditis 140103113606-phpapp02
Myocarditis 140103113606-phpapp02
 
Labs 1.08-abg-rome-flowchart
Labs 1.08-abg-rome-flowchartLabs 1.08-abg-rome-flowchart
Labs 1.08-abg-rome-flowchart
 

Recently uploaded

Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 

Recently uploaded (20)

Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 

Bloodpressurechangesduring

  • 1. Magdy El-Masry Prof. of Cardiology Tanta University CHANGES IN BLOOD PRESSURE AFTER HEMODIALYSIS
  • 2. Hemodialysis Removal of Fluid and Solutes with the Goal to Achieve “Dry Weight” What the cardiologist should know ?
  • 3.
  • 5.
  • 6.
  • 7.
  • 10. Goals of Dialysis –Solute clearance • Diffusive transport (based on countercurrent flow of blood and dialysate) • Convective transport (solvent drag with ultrafiltration) –Fluid removal
  • 11. 11
  • 12. Figure 3-2 Body Fluid Compartments
  • 13. Appropriate Removal Rate setting the fluid removal rate to not exceed the plasma refill rate (PRR) will minimize risk of hypovolemia, hypotension “Never too fast, never too much” Vascular Space Plasma Refill Rate Intravascular Hemodialysis UF rate Extravascular UFR ≤ PRR (UFR)UltrafiltrationRemoval byFluid illicits compensatory mechanisms, termed plasma or intravascular refill, aimed at minimizing this reduction
  • 14. Dialysate Buffer • Acetate: in the early 1960s became the standard dialysate buffer used to correct uremic acidosis In the mid 1980s some reported the linking between acetate and cardiovascular instability and hypotension during HD • Bicarbonate: emerged the buffer of choice
  • 15. Dialysis Solution Sodium Level Plus Minus Low dialysate sodium Less weight-gain, thirst &hypertension More hypotension, cramps High dialysate sodium Less hypotension, cramps More weight gain, thirst & hypertension
  • 16. EXCESS FLUID WEIGHT Body weight at which composition of body fluid compartments is normal. At higher weights there is expansion of compartments At lower weights there is depletion of compartments. Both these states have adverse clincal consequences. CONCEPT of DRY WEIGHT DRY WEIGHT (euvolemia)
  • 17. In short, among all these elements, the 2 essential clues are the BP and the weight
  • 18.
  • 20. Acute complications of dialysis HHCCBNF • Hypotension — 25 to 55 % • Cramps — 5 to 20 % • Nausea and vomiting — 5 to 15 % • Headache — 5% • Chest pain — 2 to 5 % • Back pain — 2 to 5 % • Itching — 5 % • Fever and chills — Less than 1 %
  • 21. Intradialytic Hypotension K/DOQI • ↓SBP≥20mmHg or ↓MAP 10mmHg with symptoms: abdominal discomfort, yawning, sighing, N/V, cramps, restlessness, anxiety, fainting
  • 22. Cardiac output Arterial Blood Pressure Diastolic filling Atrial kick Systemic vascular resistance Stroke volume preload afterload contractility Heart rate / rhythm
  • 24. Acute management of low blood pressure associated with hemodialysis Ultrafiltration should either be stopped or the rate decreased. The patient should be placed in the Trendelenburg position. The blood flow rate should be reduced. Intravascular volume may be replaced with mannitol or saline. Currently the use of an intravenous bolus of saline is the first-line therapy for hypotension.
  • 25. PREVENTION • Accurate setting of the "dry weight" • Steady, constant ultrafiltration • Increased dialysate sodium concentration and sodium modeling • Bicarbonate dialysate buffer • Decrease dialysate temperature from 37C to 34-35C
  • 26. Prevention – Con’t Improvement in cardiovascular Performance in cardiac patients. Midodrine (the selective alpha-1 adrenergic agonist) in patients with autonomic neuropathy and perhaps others with severe hemodialysis hypotension not responsive to the above measures. Avoidance of food. Avoid large interdialytic weight gain No antihypertensive before dialysis
  • 27. Intradialytic Hypertension The growing problem of intradialytic hypertension (5 – 15 % of HD patients )
  • 28. Intradialytic Hypertension Clinical Definitions • ↑MAP of ≥ 15 mmHg during or immediately post dialysis • Hypertension during 2nd or 3rd hr of HD after significant UF removed • ↑BP that is resistant to UF
  • 29. The Etiopathogenesis of Intradialytic Hypertension Hypervolemia Sodium balance positive and extracellular volume expand Increased systemic vascular resistance Increased sympathetic activity Renin-angiotensin system hyperactivity Endothelial cell dysfunction Elevated concentration of endothelin 1 Calcification of the arterial tree Increased hematocrit Erythropoietin Therapy Increased vascular stiffness Nitric oxide deficiency
  • 30. Hypertension in dialysis (Another World • There are limited studies on controlling blood pressure in patients on dialysis. • No consistent guidelines available due to the fact that no one knows what blood pressure to target. – Pre, Post, intradialytic, non-dialysis day.
  • 31. Blood pressure measurement in dialysis patients  Majority of Uremic patients lack diurnal variation in BP  Immediate pre‐dialysis and post‐dialysis are misleading and not reflective of true interdialytic BP However, a post dialytic BP is more reflective of interdialytic BP *Continuous monitoring is warranted in poor control patients (those with large interdialytic weight gain) *“Systolic load “ ‐‐ > amount of time SBP exceeds 140 mmHg per day as correlates to incidence of LVH
  • 32. K/DOQI Blood Pressure Goals in Hypertensive ESRD Patients • Target BP ≤ 140/90 mmHg (predialysis) • ≤ 130/80 mmHg (postdialysis)
  • 33. Treatment of hypertension in patients on hemodialysis Treatment of hypertension is often a multiple-step, multidisciplinary process to reach KDOQI guidelines of predialysis BP values of <140/90 mm Hg. The key to successful treatment is patience; it often takes 4-6 weeks to achieve results. (This represents the lag phenomenon )
  • 34. Chronic volume expansion Vascular Na/K ATPase NO Synthetase ADMA DLIS etc NO iCa++ Vaso- constriction Sustained UF & Na restriction ECV DLIS etc ADMA LAG BP Lag period between normalisation of ECF and optimal control of BP DLIS:digoxin-like immunoreactive substance ADMA:asymmetric-dimethyl arginine
  • 35. Treatment of Intradialytic Hypertension The step-by-step approach
  • 36.
  • 37.
  • 38. Choice of antihypertensive drugs All classes of antihypertensive drugs can be used in dialysis patients, with the sole exception of diuretics, which are not commonly used because of their lack of efficacy. Therefore, with the exceptions of diuretics, the criteria for drug selection are quite similar to those used in non-dialysis patients.
  • 39. Dialysis Clearance of Drugs In general, removal of drugs on HD has NOT been tested and is based on theoretical considerations of molecular size and chemical makeup of the drug Drugs with low MW, limited volume of distribution (Vd) , and that are water-soluble are most likely to be removed by HD and will require extra dosing
  • 40. Postdialysis dosing or extra doses after HD may be necessary for certain antihypertensive agents: •Angiotensin converting enzyme inhibitors (ACE-I): all are dialyzable except fosinopril •Angiotensin receptor blockers (ARB): none are dialyzed •B-blockers: atenolol and metoprolol are dialyzable but labetolol and carvedilol are not •Calcium channel blocker: amlodipine is not dialyzable
  • 41. Conclusions “We can do better” The fluctuations in BP with every dialysis is complex
  • 42. Intradialytic Blood Pressure Fluctuations • Current State Clinically significant alteration in blood pressures is one of the biggest challenges encountered in the dialysis unit • Ideal State Clinicians understand the physiological changes in blood pressures during hemodialysis and prevent and manage these changes effectively to ensure patient’s safety
  • 43. Thank you for your attention Gracias por su atención Danke für Ihre Aufmerksamkeit Go raibh maith agat Grazie per l´Attenzione AAp sAAb kA shukriyA… Merci pour votre attention